---
title: "XUELONG Group released its 2024 annual performance, with a net profit attributable to the parent company of 60.4097 million yuan, a year-on-year decrease of 14.43%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/233458618.md"
description: "XUELONG Group released its 2024 annual performance, with operating revenue of 360 million yuan, a year-on-year decrease of 6.26%; net profit attributable to the parent company was 60.4097 million yuan, a year-on-year decrease of 14.43%; net profit after deducting non-recurring gains and losses was 40.3610 million yuan, a year-on-year decrease of 21.31%; basic earnings per share were 0.29 yuan, and it plans to distribute a cash dividend of 0.10 yuan per share"
datetime: "2025-03-27T12:34:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/233458618.md)
  - [en](https://longbridge.com/en/news/233458618.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/233458618.md)
generator: "portal-rs"
---

# XUELONG Group released its 2024 annual performance, with a net profit attributable to the parent company of 60.4097 million yuan, a year-on-year decrease of 14.43%

According to the Zhitong Finance APP, XUELONG Group (603949.SH) released its annual report for 2024. The company's operating revenue for the year 2024 was 360 million yuan, a year-on-year decrease of 6.26%; the net profit attributable to shareholders of the listed company was 60.4097 million yuan, a year-on-year decrease of 14.43%; the net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 40.3610 million yuan, a year-on-year decrease of 21.31%; the basic earnings per share were 0.29 yuan/share. It plans to distribute a cash dividend of 0.10 yuan per share

### Related Stocks

- [603949.CN](https://longbridge.com/en/quote/603949.CN.md)

## Related News & Research

- [M Stanley: XIAOMI-W  2Q Smartphone Margin Surprise, Expects Resilience in 2H](https://longbridge.com/en/news/296303100.md)
- [Rossi Residencial files delayed 2025 financial statements after late 2024 accounts release](https://longbridge.com/en/news/296291749.md)
- [Bank of Communications schedules interim results webcast briefing](https://longbridge.com/en/news/296324060.md)
- [Orum Therapeutics Announces U.S. FDA Clearance of an IND Application for ORM-1153, a Novel CD123-GSPT1 Degrader-Antibody Conjugate](https://longbridge.com/en/news/296689195.md)
- [Liverpool and LA Lakers deals set new bar for sport investment](https://longbridge.com/en/news/296633009.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**